Smoldering Myeloma

Clinical Trials

We help myeloma patients find, understand and connect with their clinical trial options at centers around the US. Create your account today to start your personalized clinical trial report.

Create My Account

We believe...

The path towards newer, better therapies and one day a cure for myeloma, is through clinical trials. Yet, less than 1 out of every 10 myeloma patients will ever participate in a clinical trial. We're on a mission to change this.

As caregivers, we know how difficult it can be to find and understand your clinical trial options. It's why we started SparkCures.

Call us today and we can help answer any questions that you may have. You can also create your free account to get your personalized report.

Call or text us today

(888) 828-2206

Create My Account

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Verified
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratum...
MAJESTEC-3
View Trial
Verified
Phase 3, Randomized Study comparing Bortezomib, Lenolidomide, and Dexamethasone (VRd) followed by an investigational CAR-T versus VRd followed by Lenalidomid...
CARTITUDE-5
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...
SELINEXOR
View Trial
Verified
Phase 3 Study Evaluating Subcutaneous vs Intravenous Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractor...
IRAKLIA
View Trial
Verified
Phase 3 Clinical Trial Studying Isatuximab in combination with Lenalidomide and Dexamethasone in High Risk Smoldering Multiple Myeloma
ITHACA
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in P...
EXCALIBER
View Trial
Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...
SUCCESSOR-2
View Trial
Verified
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant (MagnetisMM-7)
MAGNETISMM-7
View Trial
Verified
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...
MONUMENTAL-3
View Trial
Verified
Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/...
MAGNETISMM-5
View Trial
Verified
Phase 3 Clinical Trial Comparing Iberdomide VS Lenalidomide as Maintenance Therapy Following Autologous Stem Cell Transplant in Participants with Newly Diagn...
EXCALIBER-MAINTENANCE
View Trial
Verified
Phase 3 Clinical Trial comparing the use of venetoclax combined with dexamethasone versus Pomalidomide combined with dexamethasone in Relapsed/Refractory Mul...
CANOVA
View Trial
Verified
Phase 2 Clinical Trial Evaluating the Safety, Tolerability, and Effectiveness of Venetoclax combined with Carfilzomib and Dexamethasone in Relapsed/Refractor...
VENETOCLAX
View Trial
Verified
An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies
CLOVER-1
View Trial
Verified
Phase 1B Clinical Trial Studying the Safety, Activity, and Effectiveness of Cevostamab in Treating People with Relapsed or Refractory Multiple Myeloma
CAMMA-1
View Trial
Verified
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Partic...
TTI-622
View Trial
Verified
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
MAGNETISMM-20
View Trial
Verified
Mass Accumulation Rate (MAR) as a Predictive Biomarker for Treatment Selection in Multiple Myeloma
View Trial
Verified
A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...
DREAMM8
View Trial
Verified
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myelom...
COBRA
View Trial
Verified
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
View Trial
Verified
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
View Trial
Verified
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
DESCARTES-08
View Trial
Verified
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
View Trial
Verified
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
TALQUETAMAB
View Trial
Verified
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (ADVANCE)
ADVANCE
View Trial
Verified
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
View Trial
Verified
RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma
RAPA-201 AUTOLOGOUS T CELLS
View Trial
Verified
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
IBERDOMIDE
View Trial
Verified
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
NEWLY DIAGNOSED DKRD
View Trial
Verified
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
DENOSUMAB
View Trial
Verified
Multicenter, Open-label, Single-arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Pomalidomide, Dexamethasone, and Carfilzomib (...
View Trial
Verified
Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Mu...
DREAMM5
View Trial
Verified
KRDI in Transplant-Eligible MM
View Trial
Verified
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
CC-486
View Trial
Verified
Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
View Trial
Verified
Allogeneic Hematopoietic Stem Cell Transplantation of αβ+ T Lymphocyte Depleted Grafts Conditioned with a Reduced Intensity Regimen in Patients with Hematolo...
ALLOGENEIC STEM CELL TRANSPLANT
View Trial
Verified
Descartes-25 in Relapsed/Refractory Multiple Myeloma
DESCARTES-25
View Trial
Verified
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
Verified
TriPRIL CAR T Cells in Multiple Myeloma
TRIPRIL CAR T
View Trial
Verified
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy
View Trial
Verified
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
MCARH109 AND MCARH125
View Trial
Verified
A Study of BMS-986393 (CC-95266) in Subjects With Relapsed and/or Refractory Multiple Myeloma
BMS-986393
View Trial
Verified
Personalized Autologous Transplant for Multiple Myeloma
View Trial
Verified
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
KPG-818
View Trial
Verified
Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma
ACLX-001
View Trial
Verified
Rifaximin in Patients With Monoclonal Gammopathy
RIFAXIMIN
View Trial
Verified
Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
CAR138 T-CELLS
View Trial
Verified
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
RUXOLITINIB
View Trial
Verified
A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma
DREAMM9
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480-MM-002
View Trial
Verified
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
DREAMM13
View Trial
Verified
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
DREAMM12
View Trial
Verified
Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma
CC-92328
View Trial
Verified
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)
SELVEDGE
View Trial
Verified
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
View Trial
Verified
A Study of Belantamab Mafodotin in Combination With and Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or ...
View Trial
Verified
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refr...
CA057-003
View Trial
Verified
Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma
ALNUCTAMAB
View Trial
Verified
FT576 in Subjects With Multiple Myeloma
FT576
View Trial
Verified
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
View Trial
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
View Trial
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
CONDENSED BUSULFAN, MELPHALAN, AND FLUDARABINE
View Trial
Verified
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
View Trial
Verified
In-Human CXCR4 Imaging of Blood Cancers Using [68Ga]-Pentixafor-PET
View Trial
Verified
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
View Trial
Verified
Study of CAR-T Therapy in Older Patients
View Trial
Verified
Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients
View Trial
Verified
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...
NUTRIVENTION3
View Trial
Verified
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)
PEACE
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma
View Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering ...
DETER-SMM
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE ...
EQUATE
View Trial
A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants Wi...
MAJESTEC-7
View Trial
Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates Examin...
View Trial
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...
View Trial
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
View Trial
Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Recep...
EMBRACE
View Trial
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or R...
DREAMM 14
View Trial
Marizomib Central Nervous System (CNS)
View Trial
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
MILESTONE
View Trial
Study of Lenalidomide / Ixazomib / Dexamethasone / Daratumumab in Transplant-Ineligible Patients With Newly...
View Trial
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
View Trial
A Phase 2 Adaptive Study of Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in P...
View Trial
Study of CART-ddBCMA in Relapsed or Refractory Multiple Myeloma
IMMAGINE-1
View Trial
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
View Trial
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
View Trial
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
View Trial
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myelom...
ISATUXIMAB
View Trial
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma
ISATUXIMAB
View Trial
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation B...
View Trial
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
SELINEXOR
View Trial
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate...
View Trial
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refracto...
View Trial
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
IMMUNO-PRISM
View Trial
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
View Trial
A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multip...
View Trial
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...
SELINEXOR
View Trial
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
View Trial
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
LEFLUNOMIDE
View Trial
Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
DARATUMUMAB
View Trial
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
View Trial
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating...
View Trial
Phase 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for Multiple Myeloma Patients
IXAZOMIB
View Trial
DARA RVD For High Risk SMM
PRISM
View Trial
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
View Trial
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-Ame...
View Trial
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
View Trial
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
View Trial
Standard Doses of Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or ...
View Trial
Isatuximab Plus Lenalidomide and Dexamethasone for Frail and/or Much Older Patients With Newly Diagnosed Mu...
View Trial
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
View Trial
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
View Trial
Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cel...
View Trial
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
View Trial
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Dru...
MC210809
View Trial
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
REACH
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...
D-CLAPD
View Trial
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
View Trial
CAR- PRISM (PRecision Intervention Smoldering Myeloma)
CAR-PRISM
View Trial
Phase II Study on Acalabrutinib and Anti-CD20 Antibody in Patients With Anti-MAG Mediated Neuropathy
ACALABRUTINIB
View Trial
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP
View Trial
Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
POST-TRANSPLANT MAINTENANCE THERAPY
View Trial
Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...
BELANTAMAB MAFODOTIN
View Trial
Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multipl...
View Trial
A Phase II Study of Selinexor In Addition to Lenalidomide for Consolidation and Maintenance Treatment After...
View Trial
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
View Trial
Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...
IBER-KDD
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
View Trial
Phase II Multicenter Trial of Anti-BCMA CAR T-Cell Therapy for MM Patients With Sub-Optimal Response After ...
View Trial
A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...
ISABELA
View Trial
Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
View Trial
Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...
View Trial
Phase 2 Study of Linvoseltamab in Patients With Smoldering Multiple Myeloma at High Risk of Progression to ...
View Trial
A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myel...
View Trial
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrel...
REGIMENS FOR GRAFT VERSUS HOST PREVENTION
View Trial
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANT
View Trial
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPY
View Trial
Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Tra...
POST-TRANSPLANT CYTOXAN
View Trial
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...
SCOPE
View Trial
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...
View Trial
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for the Treatment of Newly Diagnosed Multiple Myelom...
IDEAL
View Trial
Adoptive Transfer of MUC1 Activated T Cells for the Treatment of MUC1 Positive Recurrent or Refractory Mult...
View Trial
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...
BGB-11417
View Trial
A Study in Subjects With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell ...
EZM0414
View Trial
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
MONUMENTAL-2
View Trial
Ph I Study of NMS-03597812 in Adult Patients With Relapsed or Refractory Multiple Myeloma
NMS-03597812
View Trial
Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Ce...
View Trial
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
View Trial
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...
APG-2575
View Trial
Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
HDP-101
View Trial
Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma (MM FPBMC)
SLAMF7 FPBMC
View Trial
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide (COMMANDER)
COMMANDER
View Trial
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
View Trial
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Mul...
CFT7455
View Trial
A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma
ION251
View Trial
Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma
EOS884448
View Trial
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
TASQUINIMOD
View Trial
BCMA-directed CAR-T Cell Therapy in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
PHE885
View Trial
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
APG-2575
View Trial
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (...
LUMMICAR STUDY 2
View Trial
Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multipl...
ISATUXIMAB
View Trial
High Dose Ascorbic Acid for Plasma Cell Disorders
HIGH-DOSE ASCORBIC ACID
View Trial
Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
PERSONALIZED VACCINE
View Trial
Myeloma-Developing Regimens Using Genomics
MYDRUG
View Trial
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Mult...
CS1-CAR T CELLS
View Trial
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...
MONUMENTAL-1
View Trial
Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
ISB 1342
View Trial
VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia,...
VSV-HIFNBETA-NIS
View Trial
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relaps...
MAJESTEC-1
View Trial
Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
CEVOSTAMAB
View Trial
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)
CARMOB
View Trial
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed ...
CAMMA-2
View Trial
Home Based Daratumumab Administration for Patients With Multiple Myeloma
View Trial
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
CC-220
View Trial
Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
ORIC-533
View Trial
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-383 in C...
ABBV-383
View Trial
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)
P-BCMA-ALLO1
View Trial
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or ...
ABBV-453
View Trial
LMY-920 for Treatment of Relapsed or Refractory Myeloma (LMY-920-002)
LMY-920
View Trial
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
IINNOVATE-2
View Trial
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...
IBERDOMIDE (CC-220)
View Trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
SELINEXOR
View Trial
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
View Trial
Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
ISB 1442
View Trial
Autologous Memory-like NK Cell Therapy With BHV-1100 (Formerly KP1237), Low Dose IL-2 in Multiple Myeloma P...
View Trial
A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
IINNOVATE-3
View Trial
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
View Trial
Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors
View Trial
A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy...
CAMMOUFLAGE
View Trial
A Phase Ib Clinical Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A...
View Trial
A Phase 1/2 Open-label, Multicentre, Dose Escalation and Expansion Study to Investigate the Safety, Tolerab...
DREAMM-20
View Trial
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed...
View Trial
An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody®-CD38) in Relapsed or Refractory Multiple ...
GEN3014 (HEXABODY®-CD38)
View Trial
Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patient...
LINKER-MM4
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
View Trial
A Study Of TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed or Refractory Multiple Myeloma
TAK-981
View Trial
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
View Trial
A Phase 1b Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of SER-155 in Adults Unde...
View Trial
IIT2022-04-Sasine-CAR-T: A Phase 1 Single-arm, Open-label Study to Evaluate the Feasibility and Safety of C...
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
View Trial
An Open-Label, Multicenter, Phase 1 Study of IGM-2644 in Participants With Relapsed and/or Refractory Multi...
View Trial
Phase I Dose-Escalation Study of BCMA/CS1 Bispecific Chimeric Antigen Receptor (CAR)-T Cells for Relapsed/R...
View Trial
A Phase 1b/2 Study of GC012F, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell ...
GCO12F CAR-T
View Trial
A Phase Ib Study to Evaluate Safety and Persistence of ex Vivo Expanded Universal Donor NK Cells in Combina...
NK CELLS PLUS VACTOSERTIB
View Trial
Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
View Trial
Phase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory ...
View Trial
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transpl...
PALIFERMIN (KEPIVANCE)
View Trial
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multi...
INCB000928
View Trial
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...
LP-118
View Trial
Phase 1 Study of Lintivirally Transduced T Cells Engineered to Contain Anti-CD38 Linked to TCRζ and 4-1BB S...
CART 38
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
View Trial
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...
LINVOSELTAMAB
View Trial
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precurso...
TRANSFORMM
View Trial
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
View Trial
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With ...
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
View Trial
Clinical and Genomic Predictors of Progression to Myeloma in Patients With Asymptomatic Monoclonal Gammopat...
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
View Trial
Screening to Improve Survival in AL Amyloidosis
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab
View Trial
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...
HEME-20
View Trial
Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM) (MED...
MEDICI
View Trial
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
View Trial
Patient and Care Partner Experiences Living With Multiple Myeloma
PACE-MM
View Trial
Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma (MAGNETISMM17)
MAGNETISMM-17
View Trial
PROFAST Intervention in Precursor Multiple Myeloma
PROFAST
View Trial
MMRF CureCloud Research Initiative
MMRF CURECLOUD
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
View Trial
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
PROTECT
View Trial
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...
AMBIENT LIGHT
View Trial
Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
View Trial
Exploratory Study of Fluoroquinolone Resistance for Patients Undergoing Autologous Hematopoietic Stem Cell ...
View Trial
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The ...
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
View Trial
The Role of the Comprehensive Geriatric Assessment in Elderly Patients With Multiple Myeloma: A Single Cent...
View Trial
Evaluating Patient-Reported Outcomes and Wearable Data Among Individuals With Relapsed/Refractory Multiple ...
View Trial
Cardiovascular Reserve Evaluation in Survivors of Transplantation (CREST)
CREST STUDY
View Trial
The Prospective Collection, Storage and Reporting of Data on Patients
PATIENT REGISTRY: UNDERGOING STEM CELL TRANSPLANT
View Trial
An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...
APP SICP
View Trial
Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progre...
PCROWD
View Trial
Cancer Experience Registry: An Online Research Study to Understand the Experiences of Cancer Patients and C...
CER
View Trial
Carolina Senior: UNC Registry for Older Cancer Patients
REGISTRY OF OLDER PATIENTS WITH CANCER
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
IIT2023-03-Vescio-ColdCap: Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantat...
PENGUIN COLD CAP
View Trial
A Natural Experiment of Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
TRANSITIONING CARE TO SATELLITE SITE
View Trial
Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified
Phase 3, Randomized Study comparing Bortezomib, Lenolidomide, and Dexamethasone (VRd) followed by an investigational CAR-T versus VRd followed by Lenalidomid...
CARTITUDE-5
View Trial
Verified
Phase 3 Clinical Trial Comparing Iberdomide VS Lenalidomide as Maintenance Therapy Following Autologous Stem Cell Transplant in Participants with Newly Diagn...
EXCALIBER-MAINTENANCE
View Trial
Verified
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myelom...
COBRA
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
DESCARTES-08
View Trial
Verified
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (ADVANCE)
ADVANCE
View Trial
Verified
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
NEWLY DIAGNOSED DKRD
View Trial
Verified
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
DENOSUMAB
View Trial
Verified
KRDI in Transplant-Eligible MM
View Trial
Verified
Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma
DREAMM9
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480-MM-002
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE ...
EQUATE
View Trial
A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants Wi...
MAJESTEC-7
View Trial
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
MILESTONE
View Trial
Study of Lenalidomide / Ixazomib / Dexamethasone / Daratumumab in Transplant-Ineligible Patients With Newly...
View Trial
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myelom...
ISATUXIMAB
View Trial
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma
ISATUXIMAB
View Trial
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
SELINEXOR
View Trial
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
View Trial
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
View Trial
Phase 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for Multiple Myeloma Patients
IXAZOMIB
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
View Trial
Isatuximab Plus Lenalidomide and Dexamethasone for Frail and/or Much Older Patients With Newly Diagnosed Mu...
View Trial
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Dru...
MC210809
View Trial
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
REACH
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
A Phase II Study of Selinexor In Addition to Lenalidomide for Consolidation and Maintenance Treatment After...
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
View Trial
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for the Treatment of Newly Diagnosed Multiple Myelom...
IDEAL
View Trial
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
View Trial
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)
CARMOB
View Trial
Autologous Memory-like NK Cell Therapy With BHV-1100 (Formerly KP1237), Low Dose IL-2 in Multiple Myeloma P...
View Trial
Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patient...
LINKER-MM4
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
View Trial
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM) (MED...
MEDICI
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
View Trial
MMRF CureCloud Research Initiative
MMRF CURECLOUD
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
View Trial
The Role of the Comprehensive Geriatric Assessment in Elderly Patients With Multiple Myeloma: A Single Cent...
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
IIT2023-03-Vescio-ColdCap: Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantat...
PENGUIN COLD CAP
View Trial
A Natural Experiment of Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
TRANSITIONING CARE TO SATELLITE SITE
View Trial
Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratum...
MAJESTEC-3
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...
SELINEXOR
View Trial
Verified
Phase 3 Study Evaluating Subcutaneous vs Intravenous Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractor...
IRAKLIA
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in P...
EXCALIBER
View Trial
Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...
SUCCESSOR-2
View Trial
Verified
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...
MONUMENTAL-3
View Trial
Verified
Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/...
MAGNETISMM-5
View Trial
Verified
Phase 3 Clinical Trial comparing the use of venetoclax combined with dexamethasone versus Pomalidomide combined with dexamethasone in Relapsed/Refractory Mul...
CANOVA
View Trial
Verified
Phase 2 Clinical Trial Evaluating the Safety, Tolerability, and Effectiveness of Venetoclax combined with Carfilzomib and Dexamethasone in Relapsed/Refractor...
VENETOCLAX
View Trial
Verified
An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies
CLOVER-1
View Trial
Verified
Phase 1B Clinical Trial Studying the Safety, Activity, and Effectiveness of Cevostamab in Treating People with Relapsed or Refractory Multiple Myeloma
CAMMA-1
View Trial
Verified
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
MAGNETISMM-20
View Trial
Verified
Mass Accumulation Rate (MAR) as a Predictive Biomarker for Treatment Selection in Multiple Myeloma
View Trial
Verified
A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...
DREAMM8
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
DESCARTES-08
View Trial
Verified
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
View Trial
Verified
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
DENOSUMAB
View Trial
Verified
Multicenter, Open-label, Single-arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Pomalidomide, Dexamethasone, and Carfilzomib (...
View Trial
Verified
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
CC-486
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
Allogeneic Hematopoietic Stem Cell Transplantation of αβ+ T Lymphocyte Depleted Grafts Conditioned with a Reduced Intensity Regimen in Patients with Hematolo...
ALLOGENEIC STEM CELL TRANSPLANT
View Trial
Verified
Descartes-25 in Relapsed/Refractory Multiple Myeloma
DESCARTES-25
View Trial
Verified
Personalized Autologous Transplant for Multiple Myeloma
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480-MM-002
View Trial
Verified
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
DREAMM13
View Trial
Verified
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
DREAMM12
View Trial
Verified
Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma
CC-92328
View Trial
Verified
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)
SELVEDGE
View Trial
Verified
Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma
ALNUCTAMAB
View Trial
Verified
FT576 in Subjects With Multiple Myeloma
FT576
View Trial
Verified
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
View Trial
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
View Trial
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
CONDENSED BUSULFAN, MELPHALAN, AND FLUDARABINE
View Trial
Verified
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
View Trial
Verified
Study of CAR-T Therapy in Older Patients
View Trial
Verified
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)
PEACE
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...
View Trial
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
View Trial
Marizomib Central Nervous System (CNS)
View Trial
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
View Trial
Study of CART-ddBCMA in Relapsed or Refractory Multiple Myeloma
IMMAGINE-1
View Trial
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
View Trial
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
View Trial
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refracto...
View Trial
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...
SELINEXOR
View Trial
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
LEFLUNOMIDE
View Trial
Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
DARATUMUMAB
View Trial
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating...
View Trial
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
View Trial
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
View Trial
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Dru...
MC210809
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...
D-CLAPD
View Trial
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP
View Trial
Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...
BELANTAMAB MAFODOTIN
View Trial
Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...
IBER-KDD
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
View Trial
A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...
ISABELA
View Trial
Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
View Trial
Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...
View Trial
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANT
View Trial
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPY
View Trial
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...
SCOPE
View Trial
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...
View Trial
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...
BGB-11417
View Trial
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...
APG-2575
View Trial
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
HDP-101
View Trial
Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma (MM FPBMC)
SLAMF7 FPBMC
View Trial
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
View Trial
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
TASQUINIMOD
View Trial
BCMA-directed CAR-T Cell Therapy in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
PHE885
View Trial
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
APG-2575
View Trial
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (...
LUMMICAR STUDY 2
View Trial
Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multipl...
ISATUXIMAB
View Trial
Myeloma-Developing Regimens Using Genomics
MYDRUG
View Trial
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...
MONUMENTAL-1
View Trial
Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
ISB 1342
View Trial
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relaps...
MAJESTEC-1
View Trial
Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
CEVOSTAMAB
View Trial
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)
CARMOB
View Trial
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed ...
CAMMA-2
View Trial
Home Based Daratumumab Administration for Patients With Multiple Myeloma
View Trial
Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
ORIC-533
View Trial
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)
P-BCMA-ALLO1
View Trial
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
IINNOVATE-2
View Trial
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...
IBERDOMIDE (CC-220)
View Trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
SELINEXOR
View Trial
A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
IINNOVATE-3
View Trial
A Phase 1/2 Open-label, Multicentre, Dose Escalation and Expansion Study to Investigate the Safety, Tolerab...
DREAMM-20
View Trial
An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody®-CD38) in Relapsed or Refractory Multiple ...
GEN3014 (HEXABODY®-CD38)
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
View Trial
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
View Trial
IIT2022-04-Sasine-CAR-T: A Phase 1 Single-arm, Open-label Study to Evaluate the Feasibility and Safety of C...
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
View Trial
Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
View Trial
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multi...
INCB000928
View Trial
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...
LP-118
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
View Trial
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...
LINVOSELTAMAB
View Trial
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab
View Trial
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...
HEME-20
View Trial
Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM) (MED...
MEDICI
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
View Trial
Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma (MAGNETISMM17)
MAGNETISMM-17
View Trial
MMRF CureCloud Research Initiative
MMRF CURECLOUD
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
View Trial
Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
IIT2023-03-Vescio-ColdCap: Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantat...
PENGUIN COLD CAP
View Trial
A Natural Experiment of Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
TRANSITIONING CARE TO SATELLITE SITE
View Trial
Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratum...
MAJESTEC-3
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...
SELINEXOR
View Trial
Verified
Phase 3 Study Evaluating Subcutaneous vs Intravenous Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractor...
IRAKLIA
View Trial
Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...
SUCCESSOR-2
View Trial
Verified
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...
MONUMENTAL-3
View Trial
Verified
Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/...
MAGNETISMM-5
View Trial
Verified
Phase 3 Clinical Trial comparing the use of venetoclax combined with dexamethasone versus Pomalidomide combined with dexamethasone in Relapsed/Refractory Mul...
CANOVA
View Trial
Verified
Phase 2 Clinical Trial Evaluating the Safety, Tolerability, and Effectiveness of Venetoclax combined with Carfilzomib and Dexamethasone in Relapsed/Refractor...
VENETOCLAX
View Trial
Verified
An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies
CLOVER-1
View Trial
Verified
Phase 1B Clinical Trial Studying the Safety, Activity, and Effectiveness of Cevostamab in Treating People with Relapsed or Refractory Multiple Myeloma
CAMMA-1
View Trial
Verified
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Partic...
TTI-622
View Trial
Verified
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
MAGNETISMM-20
View Trial
Verified
Mass Accumulation Rate (MAR) as a Predictive Biomarker for Treatment Selection in Multiple Myeloma
View Trial
Verified
A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...
DREAMM8
View Trial
Verified
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
View Trial
Verified
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)
IMPACT
View Trial
Verified
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
TALQUETAMAB
View Trial
Verified
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
View Trial
Verified
RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma
RAPA-201 AUTOLOGOUS T CELLS
View Trial
Verified
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
DENOSUMAB
View Trial
Verified
Multicenter, Open-label, Single-arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Pomalidomide, Dexamethasone, and Carfilzomib (...
View Trial
Verified
Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Mu...
DREAMM5
View Trial
Verified
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
CC-486
View Trial
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
View Trial
Verified
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
View Trial
Verified
TriPRIL CAR T Cells in Multiple Myeloma
TRIPRIL CAR T
View Trial
Verified
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy
View Trial
Verified
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
MCARH109 AND MCARH125
View Trial
Verified
A Study of BMS-986393 (CC-95266) in Subjects With Relapsed and/or Refractory Multiple Myeloma
BMS-986393
View Trial
Verified
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
KPG-818
View Trial
Verified
Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma
ACLX-001
View Trial
Verified
Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
CAR138 T-CELLS
View Trial
Verified
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
RUXOLITINIB
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480-MM-002
View Trial
Verified
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
DREAMM13
View Trial
Verified
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
DREAMM12
View Trial
Verified
Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma
CC-92328
View Trial
Verified
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)
SELVEDGE
View Trial
Verified
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
View Trial
Verified
A Study of Belantamab Mafodotin in Combination With and Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or ...
View Trial
Verified
Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma
ALNUCTAMAB
View Trial
Verified
FT576 in Subjects With Multiple Myeloma
FT576
View Trial
Verified
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
View Trial
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
View Trial
Verified
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
View Trial
Verified
Study of CAR-T Therapy in Older Patients
View Trial
Verified
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)
PEACE
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma
View Trial
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...
DRAMMATIC
View Trial
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...
View Trial
Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Recep...
EMBRACE
View Trial
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or R...
DREAMM 14
View Trial
Marizomib Central Nervous System (CNS)
View Trial
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
View Trial
Study of CART-ddBCMA in Relapsed or Refractory Multiple Myeloma
IMMAGINE-1
View Trial
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
View Trial
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
View Trial
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refracto...
View Trial
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...
SELINEXOR
View Trial
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
LEFLUNOMIDE
View Trial
Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
DARATUMUMAB
View Trial
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating...
View Trial
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma
View Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
View Trial
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
View Trial
Standard Doses of Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or ...
View Trial
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
View Trial
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Dru...
MC210809
View Trial
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...
INVESTIGATIONAL CORD BLOOD UNITS
View Trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
CD38-TARGETED IMMUNOPET
View Trial
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...
D-CLAPD
View Trial
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
View Trial
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP
View Trial
Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...
BELANTAMAB MAFODOTIN
View Trial
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
View Trial
Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...
IBER-KDD
View Trial
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
View Trial
A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...
ISABELA
View Trial
Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
View Trial
Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...
View Trial
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANT
View Trial
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPY
View Trial
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...
SCOPE
View Trial
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...
View Trial
Adoptive Transfer of MUC1 Activated T Cells for the Treatment of MUC1 Positive Recurrent or Refractory Mult...
View Trial
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...
BGB-11417
View Trial
Ph I Study of NMS-03597812 in Adult Patients With Relapsed or Refractory Multiple Myeloma
NMS-03597812
View Trial
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
View Trial
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...
APG-2575
View Trial
Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
HDP-101
View Trial
Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma (MM FPBMC)
SLAMF7 FPBMC
View Trial
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
View Trial
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Mul...
CFT7455
View Trial
A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma
ION251
View Trial
Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma
EOS884448
View Trial
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
TASQUINIMOD
View Trial
BCMA-directed CAR-T Cell Therapy in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
PHE885
View Trial
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
APG-2575
View Trial
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (...
LUMMICAR STUDY 2
View Trial
Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multipl...
ISATUXIMAB
View Trial
High Dose Ascorbic Acid for Plasma Cell Disorders
HIGH-DOSE ASCORBIC ACID
View Trial
Myeloma-Developing Regimens Using Genomics
MYDRUG
View Trial
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Mult...
CS1-CAR T CELLS
View Trial
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...
MONUMENTAL-1
View Trial
Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
ISB 1342
View Trial
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relaps...
MAJESTEC-1
View Trial
Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
CEVOSTAMAB
View Trial
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed ...
CAMMA-2
View Trial
Home Based Daratumumab Administration for Patients With Multiple Myeloma
View Trial
Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
ORIC-533
View Trial
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)
P-BCMA-ALLO1
View Trial
LMY-920 for Treatment of Relapsed or Refractory Myeloma (LMY-920-002)
LMY-920
View Trial
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
IINNOVATE-2
View Trial
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...
IBERDOMIDE (CC-220)
View Trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
SELINEXOR
View Trial
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
View Trial
A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
IINNOVATE-3
View Trial
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
View Trial
A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy...
CAMMOUFLAGE
View Trial
A Phase 1/2 Open-label, Multicentre, Dose Escalation and Expansion Study to Investigate the Safety, Tolerab...
DREAMM-20
View Trial
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed...
View Trial
An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody®-CD38) in Relapsed or Refractory Multiple ...
GEN3014 (HEXABODY®-CD38)
View Trial
VitD3 Supplementation in Patients With Multiple Myeloma
VITAMIN D
View Trial
Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...
View Trial
A Study Of TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed or Refractory Multiple Myeloma
TAK-981
View Trial
Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma
View Trial
IIT2022-04-Sasine-CAR-T: A Phase 1 Single-arm, Open-label Study to Evaluate the Feasibility and Safety of C...
View Trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
View Trial
An Open-Label, Multicenter, Phase 1 Study of IGM-2644 in Participants With Relapsed and/or Refractory Multi...
View Trial
Phase I Dose-Escalation Study of BCMA/CS1 Bispecific Chimeric Antigen Receptor (CAR)-T Cells for Relapsed/R...
View Trial
A Phase 1b/2 Study of GC012F, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell ...
GCO12F CAR-T
View Trial
Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
View Trial
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multi...
INCB000928
View Trial
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...
LP-118
View Trial
Phase 1 Study of Lintivirally Transduced T Cells Engineered to Contain Anti-CD38 Linked to TCRζ and 4-1BB S...
CART 38
View Trial
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...
View Trial
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...
LINVOSELTAMAB
View Trial
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
View Trial
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With ...
View Trial
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
View Trial
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...
MEDULLA
View Trial
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab
View Trial
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...
HEME-20
View Trial
Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM) (MED...
MEDICI
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
View Trial
Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma (MAGNETISMM17)
MAGNETISMM-17
View Trial
MMRF CureCloud Research Initiative
MMRF CURECLOUD
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
View Trial
Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma
View Trial
ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...
View Trial
The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...
REIKI
View Trial
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
View Trial
Tissue Procurement For Hematolymphoid Conditions
TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION
View Trial
IIT2023-03-Vescio-ColdCap: Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantat...
PENGUIN COLD CAP
View Trial
A Natural Experiment of Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
TRANSITIONING CARE TO SATELLITE SITE
View Trial
Smoldering Myeloma

The following is a listing of clinical trials for patients with Smoldering Myeloma.

Verified
Phase 3 Clinical Trial Studying Isatuximab in combination with Lenalidomide and Dexamethasone in High Risk Smoldering Multiple Myeloma
ITHACA
View Trial
Verified
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
IBERDOMIDE
View Trial
Verified
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
BELANTAMAB MAFODOTIN
View Trial
Verified
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
View Trial
Verified
In-Human CXCR4 Imaging of Blood Cancers Using [68Ga]-Pentixafor-PET
View Trial
Verified
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...
NUTRIVENTION3
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering ...
DETER-SMM
View Trial
A Phase 2 Adaptive Study of Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in P...
View Trial
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
View Trial
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate...
View Trial
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
IMMUNO-PRISM
View Trial
DARA RVD For High Risk SMM
PRISM
View Trial
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
View Trial
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-Ame...
View Trial
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Dru...
MC210809
View Trial
CAR- PRISM (PRecision Intervention Smoldering Myeloma)
CAR-PRISM
View Trial
Phase 2 Study of Linvoseltamab in Patients With Smoldering Multiple Myeloma at High Risk of Progression to ...
View Trial
Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
PERSONALIZED VACCINE
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precurso...
TRANSFORMM
View Trial
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
View Trial
Clinical and Genomic Predictors of Progression to Myeloma in Patients With Asymptomatic Monoclonal Gammopat...
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
View Trial
Screening to Improve Survival in AL Amyloidosis
View Trial
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...
View Trial
PROFAST Intervention in Precursor Multiple Myeloma
PROFAST
View Trial
MMRF CureCloud Research Initiative
MMRF CURECLOUD
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
View Trial
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The ...
View Trial
Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progre...
PCROWD
View Trial
Monoclonal Gammopathy of Undetermined Significance (MGUS)

The following is a listing of clinical trials for patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).

Verified
Rifaximin in Patients With Monoclonal Gammopathy
RIFAXIMIN
View Trial
Verified
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
View Trial
Verified
In-Human CXCR4 Imaging of Blood Cancers Using [68Ga]-Pentixafor-PET
View Trial
Verified
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...
NUTRIVENTION3
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
PROMISE
View Trial
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
View Trial
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate...
View Trial
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
View Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)
TACTAM
View Trial
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precurso...
TRANSFORMM
View Trial
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
View Trial
Clinical and Genomic Predictors of Progression to Myeloma in Patients With Asymptomatic Monoclonal Gammopat...
View Trial
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
View Trial
Screening to Improve Survival in AL Amyloidosis
View Trial
PROFAST Intervention in Precursor Multiple Myeloma
PROFAST
View Trial
MMRF CureCloud Research Initiative
MMRF CURECLOUD
View Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
View Trial
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The ...
View Trial
Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progre...
PCROWD
View Trial